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Sudden Death Associated with QT Interval Prolongation and KCNQ1
Gene Mutation in a Family of English Springer Spaniels
W.A. Ware, Y. Reina-Doreste, J.A. Stern, and K.M. Meurs
Background: A 5-year-old, healthy English Springer Spaniel died suddenly 4 months after delivering a litter of 7 puppies.
Within 4 months of the dam’s death, 3 oﬀspring also died suddenly.
Hypothesis: Abnormal cardiac repolarization, caused by an inherited long QT syndrome, is thought to be responsible for
arrhythmias leading to sudden death in this family.
Animals: Four remaining dogs from the aﬀected litter and 11 related dogs.
Methods: Physical examination and resting ECG were done on the littermates and 9 related dogs. Additional tests on
some or all littermates included echocardiogram with Doppler, Holter monitoring, and routine serum biochemistry. Blood
for DNA sequencing was obtained from all 15 dogs.
Results: Three of 4 littermates examined, but no other dogs, had prolonged QT intervals with unique T-wave
morphology. DNA sequencing of the KCNQ1 gene identiﬁed a heterozygous single base pair mutation, unique to
these 3 dogs, which changes a conserved amino acid from threonine to lysine and is predicted to change protein
structure.
Conclusions and Clinical Importance: This family represents the ﬁrst documentation in dogs of spontaneous familial QT
prolongation, which was associated with a KCNQ1 gene mutation and sudden death. Although the ﬁnal rhythm could not
be documented in these dogs, their phenotypic manifestations of QT interval prolongation and abnormal ECG restitution
suggested increased risk for sudden arrhythmic death. The KCNQ1 gene mutation identiﬁed is speculated to impair the car-
diac repolarizing current IKs, similar to KCNQ1 mutations causing long QT syndrome 1 in humans.
Key words: Long QT Syndrome.
Sudden death (SD) is known to occur in dogs withpreviously undiagnosed cardiac diseases, including
various cardiomyopathies, subaortic stenosis, myocar-
ditis, and others.1–7 Although similar and several other
abnormalities are associated with SD in people, a
major cause is cardiac ion channel dysfunction (chan-
nelopathy) that adversely aﬀects action potential (AP)
generation or termination.8,9 Half of all sudden
arrhythmic cardiac deaths in people are thought to
result from a channelopathy of some type, caused
either by genetic mutation or acquired malfunction.10
Channelopathies causing long QT syndrome (LQTS)
are most common.
The QT interval represents the time of ventricular
depolarization and repolarization on the ECG. Abnor-
mally prolonged QT interval, heterogeneous repolariza-
tion, or both predisposes to potentially fatal ventricular
arrhythmias. Acquired QT prolongation can occur as a
consequence of drugs and other conditions that alter
ion channel function.10–12 In dogs, acquired QT prolon-
gation has been reported with some drugs, electrolyte
disturbances, toxins, infectious or inﬂammatory lesions,
autonomic imbalance, and metabolic disease.13–18 Con-
genital LQTS is the most common of many inherited
channelopathies identiﬁed in people; mutations in the
KCNQ1 gene underlie the largest number of
cases.10,19,20 However, inherited LQTS has not previ-
ously been documented in dogs.
An apparently normal, 5-year-old female English
Springer Spaniel (ESS) died suddenly after activity.
Four months earlier, she had delivered her only litter,
with 7 healthy pups. Within 3 months of her death, 2
oﬀspring also had SD during activity. A third littermate
was presented for evaluation; the only abnormality
found on routine clinical testing was an unusually long
QT interval for the heart rate (HR).
We hypothesized that a form of inherited LQTS was
responsible for abnormal cardiac repolarization and
sudden death in this family of dogs. Our objectives were
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to evaluate surviving littermates and related dogs for
phenotypic evidence of LQTS and a causative mutation.
Materials and Methods
Study Design
Observational case-control study.
Clinical Evaluations
The aﬀected litter consisted of 5 males and 2 females. Data
could be obtained on 2 females (pups “C” and “R”) and 2 males
(pups “E” and “T”). Nine related dogs also were evaluated,
including the litter’s sire, the dam of the aﬀected litter’s dam (pro-
band), 2 full- and 1 half-sister to the proband, and other members
of the dogs’ extended family (Fig 1). Initially, a complete history,
physical examination, resting ECG (30–40 second), thoracic
radiographs, routine serum biochemistry, indirect blood pressure
measurement, echocardiogram with Doppler, and subsequently,
24-hour Holter recording were done on pup C. All of these tests,
except radiographs, also were done on pup E.
Tests on other littermates and related dogs included, at mini-
mum, a history, physical examination, and resting ECG. Pup T
was directly examined by another veterinary cardiologist who per-
formed a complete echocardiographic examination with Doppler.
Pup R was evaluated by a local veterinarian; routine serum bio-
chemistry also was performed. Holter recordings could be
obtained on 5 dogs: pups C, E, R, T, and 1 related ESS (dog AS,
Fig 1). Blood was collected on these 13 and 2 additional dogs (P,
proband’s sire and B, full brother; Fig 1) for DNA sequencing in
search of a mutation in a candidate gene (KCNQ1) associated
with a cardiac repolarizing current. DNA samples also were
obtained from 99 unaﬀected, unrelated dogs (controls) of various
breeds. After baseline data collection, pups C, R, and E were trea-
ted with a beta-blocker (atenolol 12.5 mg PO q12h) because this
treatment has been useful in some people with LQTS. All dogs
were housed and cared for by their owners. All testing was done
in accordance with accepted clinical practice and principles of the
NIH Guide for Care and Use of Laboratory Animals.
Heart rate and standard complex measurements were deter-
mined from resting ECGs. Corrected QT intervals (QTc) were cal-
culated using Van De Water’s formula and average HR.21,22 QT
interval and preceding TQ interval durations were measured from
hard-copy resting ECGs at 50 mm/s. Ratios of QT to preceding
TQ interval were calculated for each beat. To evaluate ECG resti-
tution, mean QT/TQ ratio and the percentage of beats with QT/
TQ ratio >1 were determined for each dog.23 In addition, resting
ECGs were recorded from pup E after treatment (for >1 week)
with atenolol at 0.7 mg/kg PO q12h (dose 1) and 1 mg/kg PO
q12h (dose 2). QT and TQ intervals were measured by the same
procedure, and results were compared with baseline values.
Statistical Analysis
Data for average HR and number of heartbeats in all dogs were
normally distributed, and a t-test for equal variance with unequal
sample size was used to compare normal and aﬀected ESS dogs.
Data for QT duration and mean QT/TQ ratio were not normally
distributed and the Mann-Whitney test was used for between
group comparisons. For pup E, comparisons of mean QT duration
and QT/TQ ratio between baseline and the 2 atenolol doses were
made using the Wilcoxon Signed Rank test when data were not
normally distributed, and using a t-test for comparisons where the
test for normality was satisﬁed. Mean values  standard deviation
are reported. P < .05 was considered signiﬁcant. Analyses were
done by SAS 9.3.a
DNA Analysis
Sequences of exonic, untranslated, and splice site regions of the
canine KCNQ1 gene (ENSCAFG00000010231) were obtained
from the canine genome using the UCSC genome browser of the
Broad CanFam3.1 assembly. Ampliﬁcation primers were designed
by Primer 3 software (http://frodo.wi.mit.edu). Ampliﬁcation prim-
ers for exon 8 of the KCNQ1 gene, the exon containing the LQTS
mutation, were as follows: forward 50 catgcaggatggggtgtg; reverse
50 ctccccacccactaatcact.
Standard PCR ampliﬁcations were carried out using AccuPrime
GC-rich buﬀer A,b 2 unit/lL AccuPrime GC-rich DNA polymer-
aseb, 20 mM of each ampliﬁcation primer, and approximately
100 ng of template DNA. Samples were denatured for 3 minutes
at 95°C followed by 30 cycles of 95°C for 30 seconds, 60°C for
30 seconds, 72°C for 30 seconds, and ﬁnally 72°C for 10 minutes.
The annealing temperature was optimized (55–60°C) to accommo-
date the respective primer.
Residual ampliﬁcation primers and dNTPs were removed from
the PCR product using a single-step enzymatic cleanup kit.c
Amplicons then were sequenced on an ABI 3730XL sequencer.d
The nucleotide sequences were evaluated for sequence change
among ESS dogs, control dogs, and the published normal canine
sequence (http://genome.ucsc.edu).
A base pair change was considered possibly causative for long
QT syndrome if it: was present in dogs with QT prolongation but
not other dogs or the published canine sequence, changed a con-
served amino acid, and changed that amino acid to a diﬀerent
Fig 1. ESS family pedigree. Squares represent males; circles, females. Tested individuals identiﬁed by letters. Shaded symbols indicate
LQTS-aﬀected dogs. Open symbols indicate normal QT duration—except those with an asterisk represent dogs of unknown phenotype. A
diagonal line indicates sudden death.
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polarity, acid/base status, or structure. Any amino acid change
identiﬁed was evaluated with the Polyphen2 (http://genet-
ics.bwh.harvard.edu/pph2/) program to predict possible impact of
the amino acid substitution on the protein. Polyphen2 also was
used to determine level of conservation using the multiple
sequence alignment function (UniProtKB/UniRef100 Release
2011_12). UniProtKB was utilized to evaluate the sequence anno-
tation and determine which functional region of the protein the
amino acid substitution aﬀected (http://www.uniprot.org/).
Finally, the normal and altered sequences were evaluated for
changes that occur in the secondary structure or function with 4
protein modeling software programs, GOR4 (http://npsap
bil.ibcp.fr/cgibin/npsa_automat), SIFT (http://sift.jcvi.org),
SWISS-MODEL Workspace (http://swissmodel.expasy.org), and
Protean 3D.e
Results
A month after the adult female ESS died, a male pup
(5 months old) died suddenly after being released from
its crate and running across the room. A second pup
(male, 7 months old) died suddenly while playing out-
doors. Pup C was evaluated at 7½ months of age; other
available dogs were evaluated within the next 3 weeks.
A third male (8 months old) had SD during play
shortly before evaluation. There was no history of epi-
sodic weakness, syncope, or other abnormality in any
dog, including those that died. Routine vaccinations
and heartworm preventive had been given according to
standard recommendations. Dogs with SD were not
receiving other drugs at the time of death.
Physical examination ﬁndings on pups C, E, and R,
and 7 related dogs were normal. A soft systolic left bas-
ilar murmur was heard in pup T. The litter’s sire and
one of the sire’s half-sisters also had soft systolic mur-
murs. Other physical ﬁndings were unremarkable.
Blood pressure in pups C and E was normal (not avail-
able in others).
Resting ECGs showed normal sinus arrhythmia (9
dogs) or regular sinus rhythm (3 dogs) with HRs from
80 to 150 beats/min. Pup T had sinus tachycardia (180
beats/min). ECG measurements were normal with the
exception of unusually long QT intervals for HRs of
110–120/min in pups C, E, and R (QT, 260–270 msec;
QTc, 304–314 msec; Figs 2, 3). Other dogs had QT
intervals ranging from 160 to 230 msec (QTc, 218–
265 msec). Aﬀected dogs (pups C, E, and R) also had
large biphasic T waves not seen in the other dogs.
Echocardiogram-Doppler examinations on pups C, E,
and T showed no abnormalities. Serum biochemistry
results for pups C, E, and R were normal. All Holter
recordings showed normal sinus rhythm or sinus
arrhythmia with no ectopic complexes.
QT and TQ intervals, and QT/TQ ratios were
obtained from 50 mm/s recordings of 9–10 second
duration, during which 13–21 heartbeats occurred
(mean 16.4  2.6 beats for unaﬀected ESS and
19.7  2.3 beats for aﬀected dogs; nonsigniﬁcant diﬀer-
ence, P = .077). Average HRs ranged from 80 to 160
beats/min and were not diﬀerent between groups (mean
114  25.0 for unaﬀected dogs and 123  11.5 for
aﬀected dogs, P = .553). There was no overlap of mean
QT interval duration between normal ESS (176–
245 msec; mean, 209.9  24.3 msec) and aﬀected dogs
(267–279 msec; mean, 272.0  9.4 msec; P < .001).
Mean QT/TQ ratios ranged from 0.493 to 1.022
(mean: 0.686  0.199) in unaﬀected ESS, and from
1.055 to 1.534 (mean: 1.365  0.264) in aﬀected dogs
(P < .001). QT/TQ ratios >1 occurred in only 2 of 10
unaﬀected dogs. These dogs had the highest HRs, with
1 unaﬀected dog (HR, 150 beats/min) having QT/TQ
ratios >1 for 45% of measured heartbeats, and the
other (pup T, 160 beats/min) with QT/TQ ratios >1 for
7.1% of heartbeats. There were no cardiac cycles with
QT/TQ ratios >1 in any of the 8 other unaﬀected ESS.
In contrast, QT/TQ ratios >1 were present in 100% of
beats for pups C and R and in 62.5% of beats for pup
E.
For pup E, mean QT duration and QT/TQ ratio at
baseline (untreated) were compared to those after
>1 week of treatment at each dose of atenolol, using an
equal number of sequential heartbeats for each treat-
ment dose. Mean QT duration decreased nonsigniﬁ-
cantly between baseline and dose 1 (279  5.7 msec
versus 273  8.7 msec, P = .055) at a HR of 112 beats/
min in both ECG recordings. Mean QT duration at the
higher dose of atenolol was more prolonged
(298  17.6, P = .002 compared to untreated), but
average HR had declined to 96 beats/min during the
ECG segment used for comparison. Mean QT/TQ ratio
in pup E decreased only at the higher atenolol dose
compared to baseline (1.055  0.09 untreated;
1.039  0.14 dose 1, P = .713 versus untreated;
0.928  0.09 dose 2, P = .028 versus untreated). The
percentage of heartbeats with QT/TQ ratio >1 decreased
markedly with increasing atenolol dose for the ECG
complexes measured (62.5% untreated; 50%, dose 1;
and 19%, dose 2).
Results of KCNQ1 gene sequencing showed that the
3 dogs with QT prolongation, but no other dogs, had
a heterozygous single base pair change from cytosine
to adenine in codon 1 of exon 8 (Fig 4). This changes
a highly conserved amino acid in the protein tran-
script from threonine (T), a nonaromatic, neutral
hydrophilic amino acid, to lysine (K), a basic posi-
tively charged amino acid at position 377 (Genbank
KF439050; KCNQ1_T377K). Altered protein structure
is predicted (Fig 5). The protein structure analysis
program GOR4 predicted an increase in the extended
strand and a decrease in the random coil within the
domain containing the mutation. The SWISS-MODEL
Workspace program predicted a 3-dimensional model
of the normal and mutant KCNQ1 C-terminus cyto-
plasmic protein region, which further conﬁrmed reduc-
tion in random coil and increased extended strand
structure. Commercial software (Protean 3D) was used
to further analyze the SWISS-MODEL output ﬁles
with the following results: Chou-Fasman analysis of
secondary structure indicated removal of a beta region
and extension of the neighboring alpha region in the
mutant protein; Kyte-Doolittle hydropathy analysis
indicated decreased hydrophobicity in the mutant pro-
tein; and Lehninger charge density evaluation
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indicated creation of a positive charge region in the
mutant protein.
After initial data collection and in addition to beta-
blocker treatment, avoidance of strenuous activity and
excitement was recommended for the 3 aﬀected dogs.
Nevertheless, Pup C died suddenly after going outside
within 2 months of initial evaluation (9 months of age).
Pup R’s owners decided to discontinue atenolol after a
few weeks; SD occurred while running at 15 months of
age. Pup E developed progressive unprovoked aggres-
sion toward children and was euthanized per owner
request at 20 months of age. No cardiovascular abnor-
malities were found at necropsy.
Discussion
This study represents the ﬁrst report of familial
LQTS in the dog, with the identiﬁed KCNQ1 gene
mutation apparently arising de novo in the dam of the
aﬀected litter. The clinical presentation was similar to
LQTS in humans in which the ﬁrst sign often is SD. It
was characterized phenotypically by prolonged QT
intervals in the absence of any pharmacologic manipu-
lation or evidence of cardiac or other systemic disease.
None of these ESS showed any indication of familial
atrial standstill or ventricular dysfunction.
The QT interval duration, extending from the onset
of the QRS complex to the end of the T wave, is deter-
mined by ventricular cell AP duration in aggregate.
Factors that delay repolarization prolong the QT inter-
val. Electrophysiologically, this includes reduction in
outward K+ ﬂux during phases 2 and 3, especially of
either the slow (IKs) or rapid (IKr) components of the
IK (delayed rectiﬁer) current, or enhanced inward Na
+
or Ca++ current during depolarization.10 Repolariza-
tion delay predisposes to potentially lethal arrhythmias
from triggered activity, reentrant mechanisms, or
both.24 Decreased outward K+ current, by prolonging
phase 2 and allowing Ca++ channels to partially
recover from inactivation, can facilitate development of
early after-depolarizations that may trigger premature
ventricular depolarization. In addition, regional dispar-
ity in ventricular repolarization and refractoriness facili-
tates development of reentrant ventricular tachycardia.
The polymorphic ventricular tachycardia known as Tor-
sades de Pointes (TdP) is commonly associated with
LQTS. TdP often degenerates to ventricular ﬁbrilla-
tion.10,24
QT duration varies with changes in HR, largely
reﬂecting underlying cardiac autonomic inﬂuences.
Therefore, QT duration is considered in the context of
HR. Several equations have been developed to describe
the QT-HR relationship or to “correct” QT interval
duration for HR, although these all have limitations.
In people, QTc usually is calculated using the RR
interval from the preceding beat (ie, instantaneous
HR). In dogs, respiratory sinus arrhythmia generally
produces marked variability in RR intervals. However,
QT duration remains essentially unchanged during
respiratory sinus arrhythmia despite large changes in
A B
Fig 2. ECGs from an aﬀected (A, pup E) and normal (B) ESS at HR of 120/min. Note prolonged QT duration (270 msec; QTc 310 msec)
and large biphasic T waves in A. Leads marked, 50 mm/s, 1 cm = 1 mV.
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beat-to-beat intervals because more beats than occur
during a respiratory cycle are required for ionic con-
ductance to reach a new steady state for the new HR
(so-called “QT memory”).21,23 Although not perfect, we
used Van de Water’s correction formula, with mean
RR interval calculated from mean HR (over 6–10
seconds), to normalize the QT interval to an RR inter-
val of 1000 msec (HR of 60 beats/min):
QTc = QT  0.087(RR-1000), with QT and RR in
msec. Commonly used correction formulas in people
(eg, Bazett’s or Fridericia’s) tend to overestimate QTc
at higher HRs and underestimate QT prolongation at
lower HRs.21,22,25–27 Although, as in people, there may
be no clear cut-oﬀ between normal and abnormal QTc
in the larger canine population, the QTc calculations in
these dogs showed a clear distinction between unaf-
fected and aﬀected dogs.
The utility of QTc formulas for distinguishing ar-
rhythmogenic repolarization abnormalities from physio-
logic variation is limited however, because they do not
account for physiologic changes in autonomic state or
QT hysteresis on the QT-RR relationship.10,28 During
increased vagal inﬂuence (eg, exhalation), there is little
change in QT duration at long RR intervals (slow HR).
However, as vagal tone decreases and sympathetic inﬂu-
ence increases, the QT-RR relationship becomes steeper.
This creates a dynamic oscillation between ﬂatter and
steeper QT-RR relationships, which QTc formulas can-
not reliably predict.28
A newer technique for assessing arrhythmia vulnera-
bility involves the generation of beat-to-beat QT-RR
plots (QT “clouds”) from 5- to 10-minute ECG record-
ings to diﬀerentiate physiologic variation in the QT
interval caused by changing HR and autonomic inﬂu-
ence from impaired repolarization.28 This beat-to-beat
method also is used to evaluate ECG restitution by
plotting QT to preceding TQ intervals. ECG restitution
is the ability of the heart to recover from 1 beat to the
next. 28 It describes the “work” phase (QT interval) in
relation to the preceding “rest” phase (TQ interval).
This also is a dynamic relationship that varies with
autonomic state as well as abnormal repolarization
delay. The mean QT/TQ ratio and percent heartbeats
with QT/TQ ratio >1 are also ECG biomarkers of resti-
tution. In the normal unstressed heart, “rest” time
exceeds “work” time and the QT/TQ ratio is <1. How-
ever with exercise (tachycardia) or other stress, this
ratio may be >1 because the TQ shortens to a greater
extent than does the QT. Sustained periods of QT/TQ
>1 are thought to represent inadequate recovery time
A
B
Fig 3. ECGs from aﬀected pup C, QT duration 270 msec (A); and pup R, QT duration 260 msec (B). 50 mm/s.
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between beats and increased vulnerability to arrhyth-
mia.23,28 QT prolongation, especially with increased
repolarization heterogeneity, magniﬁes this risk. The
percentage of beats with QT/TQ >1 reﬂects the relative
time spent on the restitution curve during which electri-
cal stability is questionable. Healthy people have <25%
of beats with QT/TQ >1; normal dogs appear to have
fewer, and 5% was reported in 1 study.23,28 An increase
in mean QT/TQ ratio and higher percentage of beats
with QT/TQ >1 have been correlated with increased ar-
rhythmogenicity in people and have been observed
experimentally in dogs after administration of ar-
rhythmogenic substances.23,28
Although we were unable to apply beat-to-beat meth-
ods in our dogs because we lacked extended ECG
recordings on all dogs, as well as the required software,
we attempted to generate “snapshots” of ECG restitu-
tion using brief resting ECGs of consistent duration
and recording conditions. We acknowledge that sinus
arrhythmia might be a confounding factor in our brief
recordings, however, most dogs had fairly regular sinus
rhythm at the time. Furthermore, the ECGs would have
Fig 4. A heterozygous C to A nucleotide change was identiﬁed in the 3 dogs labeled “aﬀected”. The 3 normal dogs match the reference
sequence and are homozygous for the wild type C in position 2, codon 1, exon 8 of the KCNQ1 gene
A B
Fig 5. Protein models (SWISS-MODEL) of the KCNQ1 gene, C-
terminus region, demonstrating normal protein sequence (A) and
mutant protein sequence (B). Note loss of random coil and
increased extended strand in (B) compared to normal (arrows).
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been long enough to encompass 3–5 respiratory cycles,
allowing measurements at diﬀerent levels of autonomic
tone. Although this approach has not been fully vali-
dated, and the duration of our ECGs was limited, it did
identify clear diﬀerences between groups. The increased
mean QT/TQ ratios and markedly increased percentage
of heartbeats with QT/TQ >1 despite lower HRs in
LQTS dogs is consistent with prolonged repolarization
and increased risk for lethal arrhythmias. Indeed, the
dogs that had 100% of heartbeats with QT/TQ >1 did
experience SD.
Inherited long QT syndrome in people has a preva-
lence estimated at 1:2,500–5,000 individuals, with 13
LQTS forms now reported.10 About 70–75% of human
LQTS cases result from mutations in 3 major genes:
KCNQ1, KCNH2 (hERG), and SCN5A.9,20 Respec-
tively, these genes code for the alpha subunits of the
slow-activating delayed rectiﬁer potassium current (IKs),
the rapid-activating delayed rectiﬁer potassium current
(IKr), and the fast inward sodium current (INa).
Approximately, 35% of positive LQTS genetic tests in
people are caused by loss-of-function mutations in the
KCNQ1 gene, causing LQT1.20 To the authors’ knowl-
edge, no examples of familial LQTS have been docu-
mented previously in dogs or other animals. The
missense mutation in KCNQ1 discovered in these 3
aﬀected ESS dogs, which changes a highly conserved
amino acid, appears to have eﬀects similar to those in
people with LQT1, although this speciﬁc mutation has
not been reported in people.
Common clinical manifestations in humans with
LQTS include syncope and a high risk of TdP, which
may spontaneously terminate or progress to ventricular
ﬁbrillation.10,19 Sudden cardiac death often is the ﬁrst
sign of disease, as was observed in the dogs of this
report. In humans with LQTS, the severity of clinical
signs can vary even among people with the same muta-
tion and within the same family. This clinical heteroge-
neity in phenotypic expression in patients with the same
mutation may relate to the complex interactions
between membrane ion channels and other membrane
proteins as well as the intra- and extracellular environ-
ment.20
There are genotype-speciﬁc triggers associated with
LQTS cardiac events in people. Those with LQT1 are
reportedly the most sensitive to sympathetic stimula-
tion, and cardiac events most often occur during exer-
cise. KCNQ1 mutations not only can cause a decrease
in IKs, but also decrease channel activation in response
to beta-adrenergic stimulation, which paradoxically
increases QT duration (and the risk of life-threatening
arrhythmias) during exercise and during other times of
sympathetic activation.29 The occurrence of SD in these
ESS dogs while they were playing or running (and pre-
sumably excited) is consistent with the observations in
people with LQT1.
A broad-based, prolonged T-wave morphology com-
monly is observed in people with LQT1.10,19 In studies of
a canine experimental model of LQT1 employing a IKs
blocker, the addition of the beta-agonist isoproterenol
induced preferential AP duration prolongation in mid-
myocardial (M) cells compared to cells near the epicar-
dium and endocardium. The modiﬁed K+ current greatly
increased the transmural heterogeneity of repolarization
and resulted in large, broad-based T waves.19,30 The T
waves of the aﬀected ESS dogs in which ECGs were
available all showed wide and pronounced negative-posi-
tive biphasic conﬁguration in Lead II. This was thought
to reﬂect increased spatial heterogeneity of repolarization
in these dogs. None of the other ESS ECGs had clearly
biphasic T waves, although a few had subtle notching of
a positive T wave.
Human males with LQT1 are more likely to experi-
ence a ﬁrst cardiac event at an earlier age than females.
However, the risk for SD in aﬀected females becomes
greater than for males during adulthood, with risk
reversal occurring during the mid-teens.19,24 Although
the number of dogs reported here is too small for statis-
tical signiﬁcance, the dam of the aﬀected litter was
ostensibly normal until SD at 5 years of age, whereas 3
male pups were the ﬁrst to die.
Beta-blockers are helpful in preventing syncope and
sudden death in people with LQT1.19 Improved ECG
restitution, as implied by the decreased percentage of
heartbeats with QT/TQ >1 in pup E after atenolol, is
thought to decrease arrhythmia risk. Other recommenda-
tions include exercise restriction, and avoidance of hypo-
kalemia and drugs known to prolong the QT interval.
This study has a number of limitations, especially the
fact that the dam and 3 pups were not available for
study. Also, because ECG recordings were not available
at the time of SD, we could not document an arrhyth-
mia as the cause of death. Unfortunately, necropsy
examinations were not available on dogs with SD.
However, none of the 5 littermates with SD or their
dam showed any evidence of decreased exercise toler-
ance or other signs of underlying myocardial disease.
Likewise, clinical and echocardiographic ﬁndings on the
pups examined did not indicate the presence of myocar-
dial disease. Despite the large percentage of aﬀected
dogs in this litter, the total number of aﬀected dogs was
small. Nevertheless, the ﬁndings reported here are
important because this family of ESS represents the ﬁrst
report of inherited LQTS in dogs, along with an associ-
ated, novel KCNQ1 mutation.
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